MEPE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of monoclonal MEPE Antibodies for various research applications. Matrix extracellular phosphoglycoprotein (MEPE) monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Matrix extracellular phosphoglycoprotein (MEPE) plays a crucial role in bone mineralization and is involved in the regulation of phosphate metabolism. MEPE is primarily expressed in bone and dentin, where it contributes to the mineralization process and influences osteoblast and osteoclast activity. Understanding matrix extracellular phosphoglycoprotein (MEPE) is essential for elucidating mechanisms related to bone diseases and mineralization disorders. Researchers studying bone development and mineralization can utilize matrix extracellular phosphoglycoprotein (MEPE) monoclonal antibodies to explore cellular pathways and protein interactions. Matrix extracellular phosphoglycoprotein (MEPE) monoclonal antibodies enable detailed examination of bone metabolism and mineral homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of bone biology and mineral regulation.